Related Experiment Video
Updated: Aug 4, 2025
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
A progressive T cell exhaustion program mapped across tissues in patients with lung cancer on immune checkpoint
Carolina Mangana1, Barbara B Maier1
1CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, 1090 Vienna, Austria.
Abstract:
Immune checkpoint blockade has reached the standard of care for patients with lung cancer. However, its mode of action in patients is still incompletely understood. In this issue, Pai et al. present a temporally and spatially resolved differentiation map of tumor-directed T cells in patients with lung cancer on PD-1 blockade.
Insights
Researchers mapped T-cell differentiation in lung cancer patients receiving PD-1 blockade immunotherapy. This study provides new insights into how these treatments work in patients, improving our understanding of immune checkpoint blockade efficacy.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Immune checkpoint blockade, particularly PD-1 blockade, is a standard therapy for lung cancer.
- The precise mechanisms of action for immune checkpoint blockade in patients remain incompletely understood.
Purpose of the Study:
- To create a detailed map of T-cell differentiation in lung cancer patients undergoing PD-1 blockade.
- To elucidate the temporal and spatial dynamics of tumor-directed T-cells during immunotherapy.
Main Methods:
- Longitudinal analysis of T-cell populations.
- Single-cell technologies to resolve differentiation states.
- Spatially resolved immune profiling within tumors.
Main Results:
- Identification of distinct T-cell differentiation trajectories under PD-1 blockade.
- Characterization of T-cell states that correlate with treatment response.
- Mapping the spatial distribution of differentiated T-cells within the tumor microenvironment.
Conclusions:
- The study provides a comprehensive map of T-cell differentiation during PD-1 blockade in lung cancer.
- Understanding these T-cell dynamics can inform the development of more effective immunotherapies.
- This work deepens our knowledge of anti-PD-1 mechanisms in the clinical setting.
